24th Drug Design & Development Seminar (DDDS) 2024 of the German Society for Parasitology (DGP)
“Combining Efforts towards Human and Animal Parasitic Diseases"
Date: March 13th – 15th, 2024
Venue: The Biocenter of the University of Würzburg, Germany
On the occasion of the 24th DDDS conference you are cordially invited to participate and to present your research in an oral presentation (15 minutes) or as poster. An abstract is requested for both talks and posters (abstract guideline: link). The scientific board will select the topics for oral presentations or posters depending on the abstracts. Renowned international keynote speakers will provide a high-quality scientific framework. The seminar will be opened with a welcome reception on Tuesday evening and conclude Friday at noon.
Extended Deadline for registration is December 15th, 2023
Extended Deadline for abstract submission is January 6th, 2024
Keynote Speakers
Roger Prichard McGill University, Montreal, Canada
Raffi V. Aroian University of Massachusetts, Worcester, USA
Natcha Gaillard ASTRA Therapeutics, Villigen, Switzerland
Ashwani Sharma ASTRA Therapeutics, Villigen, Switzerland
Stephen R. Doyle Wellcome Sanger Institute, Hinxton, Cambridge, UK
Mike Barrett University of Glasgow, UK
Petr Volf Charles University, Prague, Czech Republic
Jennifer Keiser Swiss Tropical and Public Health Institute, Allschwil, Switzerland
Simone Häberlein Justus-Liebig-Universität Giessen, Germany
Scientific Board
Prof. Dr. Klaus Brehm
University of Würzburg, Germany
Prof. Dr. Markus Engstler
University of Würzburg, Germany
Prof. Dr. Paul M. Selzer
Boehringer Ingelheim Animal Health
Ingelheim am Rhein, Germany
Dr. Sandra Noack
Boehringer Ingelheim Animal Health
Ingelheim am Rhein, Germany
Organizer
German Society for Parasitology & University of Würzburg
Venue
The Biocenter of the University of Würzburg
Am Hubland
97074 Würzburg
About the Drug Design & Development Seminar (DDDS)
The Drug Design & Development Seminar (DDDS) was founded in 1999 as an active working group of the German Society for Parasitology, by Prof. Dr. Peter Köhler (Univ. of Zürich, CH), Prof. Dr. Rolf Walter (BNI, Hamburg, DE), and Prof. Dr. Heiner Schirmer (Univ. of Heidelberg, DE). Since 2004 Prof. Dr. Paul M. Selzer (Boehringer Ingelheim Animal Health, Ingelheim, DE) is the coordinator of the DDDS transferring the meeting into an international well recognized scientific forum. Exchange of scientific information about anti-parasitic chemotherapy between universities, industry, and other research organizations continues to be important to accelerate anti-parasitic drug development. The DDDS is open to all scientists and professionals interested in the field of anti-parasitic research. The DDDS aims at connecting human and veterinary health by complementary approaches in medical and veterinary parasitology and medicinal chemistry to aim and stimulate One-Health approaches to combat parasitic diseases. The main topics include but are not limited to:
- Target identification, characterization, and validation
- Identification of compounds
- Synthesis and optimization of lead compounds towards marketable drugs
- Testing active compounds in animal models
